当前位置: 首页 > 期刊 > 《第一军医大学学报》 > 2006年第2期
编号:10976115
曲美他嗪对冠心病患者胰岛素抵抗的临床观察
http://www.100md.com 《南方医科大学学报》 2006年第2期
胰岛素,,冠心病;曲美他嗪;胰岛素抵抗Effect,of,trimitazidine,on,insulin,resistance,in,patients,with,coronary,heart
     摘要:目的 观察曲美他嗪对冠心病患者胰岛素抵抗的影响。 方法 将119例冠心病患者随机分为A、B两组。两组基本用药相同,B组另给曲美他嗪20 mg,3次/d,疗程8周。观察治疗前后血糖、胰岛素水平及胰岛素敏感指数的变化。 结果 B组与A组对比,治疗后空腹血胰岛素和服糖后2 h胰岛素降低(P<0.01),胰岛素敏感指数增大(P<0.01)。 结论 曲美他嗪对冠心病伴胰岛素抵抗有一定的临床疗效。

    关键词:冠心病;曲美他嗪;胰岛素抵抗

    Effect of trimitazidine on insulin resistance in patients with coronary heart disease

    CAI Jian-sheng, PENG Zhi-jian

    Department of Cardiology, Second People's Hospital of Shantou, Shantou 515011, China

    Abstract: Objective To evaluate the efficacy of trimetazidine on insulin resistance in patients with coronary heart disease (CHD). Methods A cohort of 119 CHD patients were randomly divided in groups A and B receiving the same basic therapy, and the patients in group B were given additional trimetazidine 20 mg 3 times daily for 8 weeks. Before and after treatment, the changes in blood glucose, insulin levels and insulin sensitivity index were evaluated. Results The patients in group B showed better outcome than those in group A. After 8 weeks’ trimetazidine therapy, the fasting insulin and that 2 h after oral glucose were decreased (P<0.01), and the insulin sensitivity index was improved (P<0.01). Conclusion Trimetazidine may produce obvious therapeutic effect on insulin resistance in CHD patients. ......

您现在查看是摘要页,全文长 7495 字符